New antibiotic combo tested in kidney patients
NCT ID NCT07104162
First seen Nov 01, 2025 · Last updated Jun 20, 2026 · Updated 32 times
Summary
This early-stage study is testing an experimental antibiotic combination called Cefiderocol/Xeruborbactam in 40 people with different levels of kidney function. Researchers want to see how safe the drug is and how the body processes it after a single dose. The goal is to learn the right dose for patients with kidney impairment.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BACTERIAL INFECTIONS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Orlando Clinical Research Center
RECRUITINGOrlando, Florida, 32809, United States
Contact
Contact
-
University of Miami Clinical Pharmacology
RECRUITINGMiami, Florida, 33136, United States
Contact
Contact
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Cefiderocol/Xeruborbactam (an experimental antibiotic combination given through a vein)
What this could lead to
If successful, this study could help doctors understand how to safely dose this antibiotic in patients with kidney problems.
What could go wrong
This is a very early, small Phase 1 study focused on safety and drug levels, not on treating infections. It may not lead to a new treatment or may show unexpected side effects.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.